MCP
NXTM

Moab Capital Partners’s NxStage Medical Inc. NXTM Stock Holding History

Moab Capital Partners’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-542,725
Closed -$15.1M – 34
2018
Q3 		$15.1M Buy
542,725
+316,362
+140% +$8.9M 3.32% 8
2018
Q2 		$6.32M Buy
+226,363
New +$6.07M 1.53% 18

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Moab Capital Partners's NXTM Position: Q4 2018 in Review

Moab Capital Partners sold out of NxStage Medical Inc. (NXTM) in Q4 2018, closing a stake of 542,725 shares — an estimated $15.1M sold.

Moab Capital Partners first reported a position in NXTM in Q2 2018 and held it in 2 quarters. The position peaked at $15.1M in Q3 2018. 172 funds tracked by Wall St. Rank hold NXTM as of Q4 2018.

  • Moab Capital Partners reported no remaining NxStage Medical Inc. position as of Q4 2018 after selling out during the quarter.
  • Moab Capital Partners sold 542,725 NxStage Medical Inc. shares in Q4 2018, an estimated $15.1M.
  • Moab Capital Partners first reported a position in NxStage Medical Inc. in Q2 2018 and held it in 2 quarters.
  • Moab Capital Partners's NxStage Medical Inc. position peaked at $15.1M in Q3 2018.
  • 172 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q4 2018.

Based on Moab Capital Partners's 13F filing for Q4 2018, filed 14 Feb 2019.